Jan 22 (Reuters) - Shanghai Fosun Pharmaceutical
600196.SS :
* SAYS IT PLANS TO BUY BACK 300-600 MILLION YUAN
($41.28-82.57
million) OF COMPANY A-SHARES BETWEEN JAN 22 AND JULY 21
* SAYS IT PLANS TO BUY BACK UP TO 27.6 MILLION COMPANY
H-SHARES
WITHIN SAME PERIOD
* SAYS UNIT'S PLAN TO MERGE WITH HENLIUS BIOTECH FAILED TO
PASS
HENLIUS'S SHAREHOLDER MEETING
Source text
Source text 2
Source text 3
Further company coverage: 600196.SS
($1 = 7.2666 Chinese yuan renminbi)
(Reporting by Beijing Newsroom)
((yukun.zhang@thomsonreuters.com;))